Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family. 

Education

Biotechnology

Pyramid Biosciences

Jeffrey Wasserman

Biren Amin

Nushmia Khokhar

The Scientific Team at Pyramid Biosciences conducts cutting-edge research to identify and develop new therapeutic compounds targeting tropomyosin receptor kinase (TRK) family-related disorders. This team of twelve Scientific Advisors collaborates to advance scientific understanding and innovation in TRK-targeted treatments.

Scientific Team

About

Team members

Other teams at Pyramid Biosciences

Leadership Team